{"id":18227,"date":"2023-06-01T16:45:24","date_gmt":"2023-06-01T06:45:24","guid":{"rendered":"https:\/\/mvec.mcri.edu.au\/?p=18227"},"modified":"2023-06-01T16:45:24","modified_gmt":"2023-06-01T06:45:24","slug":"atagi-%e5%85%b3%e4%ba%8e%e4%bc%98%e5%85%88%e4%bd%bf%e7%94%a8%e4%ba%8c%e4%bb%b7-covid-19-%e7%96%ab%e8%8b%97%e7%94%a8%e4%ba%8e-12-%e5%b2%81%e6%88%96%e4%bb%a5%e4%b8%8a%e4%ba%ba%e7%be%a4%e5%88%9d%e6%ac%a1","status":"publish","type":"post","link":"https:\/\/mvec.mcri.edu.au\/zh\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/","title":{"rendered":"ATAGI \u5173\u4e8e\u4f18\u5148\u4f7f\u7528\u53cc\u4ef7 COVID-19 \u75ab\u82d7\u5bf9 12 \u5c81\u6216\u4ee5\u4e0a\u4eba\u7fa4\u8fdb\u884c\u521d\u6b21\u63a5\u79cd\u7684\u5efa\u8bae"},"content":{"rendered":"<p><span data-contrast=\"auto\">ATAGI has reviewed the latest evidence regarding the use of bivalent COVID-19 vaccines. It is now recommended that individuals aged 12 years and over receive bivalent\u00a0vaccines\u00a0for primary vaccination and booster doses in preference over using the original\/ancestral strain vaccines. Whilst safety and immunogenicity data for bivalent vaccines in a primary series is limited, the safety profile when\u00a0used as a booster dose is similar to when original\/ancestral vaccines are used.\u00a0 <\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559685&quot;:0,&quot;335559737&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"14\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Individuals aged 12-17 years are recommended to receive BA.4\/5-containing bivalent vaccines for primary vaccination and booster doses.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"14\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Individuals aged 18 years and over can receive either BA.1-containing or BA.4\/5-containing vaccines for primary vaccination and booster doses.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li>Individuals aged 12 and over who have commenced their primary course with an original (ancestral) vaccine are recommended to complete the course with a bivalent vaccine.<\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"14\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" aria-setsize=\"-1\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"auto\">There are no bivalent vaccines currently available for use in children aged 6 months-11 years and therefore original\/ancestral strain vaccines should continue to be used (noting that booster doses are not recommended for anyone under 5 years of age).<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">There are no changes to who is recommended to receive booster doses. Schedules and intervals between doses also remain unchanged.<\/span><\/p>\n<p><a href=\"https:\/\/www.health.gov.au\/news\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older?language=en\" target=\"_blank\" rel=\"noopener\"><span class=\"TextRun SCXW134655446 BCX0\" lang=\"EN-GB\" xml:lang=\"EN-GB\" data-contrast=\"auto\"><span class=\"NormalTextRun CommentStart CommentHighlightPipeRest CommentHighlightRest SCXW134655446 BCX0\">ATAGI<\/span><span class=\"NormalTextRun CommentHighlightRest SCXW134655446 BCX0\"> advice\u00a0on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older<\/span><\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ATAGI \u5ba1\u67e5\u4e86\u6709\u5173\u4f7f\u7528\u4e8c\u4ef7 COVID-19 \u75ab\u82d7\u7684\u6700\u65b0\u8bc1\u636e\u3002\u73b0\u5728\u5efa\u8bae 12 \u5c81\u53ca\u4ee5\u4e0a\u7684\u4e2a\u4eba\u4f18\u5148\u63a5\u79cd\u4e8c\u4ef7\u75ab\u82d7\u8fdb\u884c\u521d\u6b21\u63a5\u79cd\u548c\u52a0\u5f3a\u5242\u91cf\uff0c\u800c\u4e0d\u662f\u4f7f\u7528\u539f\u59cb\/\u7956\u5148\u83cc\u682a\u75ab\u82d7\u3002<\/p>","protected":false},"author":493,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"no","_lmt_disable":"","footnotes":"","_wp_rev_ctl_limit":""},"categories":[87,8,10],"tags":[],"class_list":["post-18227","post","type-post","status-publish","format-standard","hentry","category-news","category-covid-19","category-external"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older - The Melbourne Vaccine Education Centre (MVEC)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mvec.mcri.edu.au\/zh\/atagi-\u5173\u4e8e\u4f18\u5148\u4f7f\u7528\u4e8c\u4ef7-covid-19-\u75ab\u82d7\u7528\u4e8e-12-\u5c81\u6216\u4ee5\u4e0a\u4eba\u7fa4\u521d\u6b21\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older - The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"og:description\" content=\"ATAGI has reviewed the latest evidence regarding the use of bivalent COVID-19 vaccines. It is now recommended that individuals aged 12 years and over receive bivalent\u00a0vaccines\u00a0for primary vaccination and booster doses in preference over using the original\/ancestral strain vaccines.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mvec.mcri.edu.au\/zh\/atagi-\u5173\u4e8e\u4f18\u5148\u4f7f\u7528\u4e8c\u4ef7-covid-19-\u75ab\u82d7\u7528\u4e8e-12-\u5c81\u6216\u4ee5\u4e0a\u4eba\u7fa4\u521d\u6b21\/\" \/>\n<meta property=\"og:site_name\" content=\"The Melbourne Vaccine Education Centre (MVEC)\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-01T06:45:24+00:00\" \/>\n<meta name=\"author\" content=\"Alice Black\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alice Black\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/\"},\"author\":{\"name\":\"Alice Black\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\"},\"headline\":\"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older\",\"datePublished\":\"2023-06-01T06:45:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/\"},\"wordCount\":232,\"articleSection\":[\"Show all\",\"COVID-19\",\"External News\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/\",\"name\":\"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older - The Melbourne Vaccine Education Centre (MVEC)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\"},\"datePublished\":\"2023-06-01T06:45:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#website\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/\",\"name\":\"The Melbourne Vaccine Education Centre (MVEC)\",\"description\":\"Find all your vaccine related infos here.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/#\\\/schema\\\/person\\\/b6f69ebc60314c6d952badec26f9c311\",\"name\":\"Alice Black\",\"url\":\"https:\\\/\\\/mvec.mcri.edu.au\\\/zh\\\/author\\\/alice-black\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATAGI \u5173\u4e8e\u4f18\u5148\u4f7f\u7528\u4e8c\u4ef7 COVID-19 \u75ab\u82d7\u5bf9 12 \u5c81\u6216\u4ee5\u4e0a\u4eba\u7fa4\u8fdb\u884c\u521d\u6b21\u63a5\u79cd\u7684\u5efa\u8bae - \u58a8\u5c14\u672c\u75ab\u82d7\u6559\u80b2\u4e2d\u5fc3 (MVEC)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mvec.mcri.edu.au\/zh\/atagi-\u5173\u4e8e\u4f18\u5148\u4f7f\u7528\u4e8c\u4ef7-covid-19-\u75ab\u82d7\u7528\u4e8e-12-\u5c81\u6216\u4ee5\u4e0a\u4eba\u7fa4\u521d\u6b21\/","og_locale":"zh_CN","og_type":"article","og_title":"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older - The Melbourne Vaccine Education Centre (MVEC)","og_description":"ATAGI has reviewed the latest evidence regarding the use of bivalent COVID-19 vaccines. It is now recommended that individuals aged 12 years and over receive bivalent\u00a0vaccines\u00a0for primary vaccination and booster doses in preference over using the original\/ancestral strain vaccines.","og_url":"https:\/\/mvec.mcri.edu.au\/zh\/atagi-\u5173\u4e8e\u4f18\u5148\u4f7f\u7528\u4e8c\u4ef7-covid-19-\u75ab\u82d7\u7528\u4e8e-12-\u5c81\u6216\u4ee5\u4e0a\u4eba\u7fa4\u521d\u6b21\/","og_site_name":"The Melbourne Vaccine Education Centre (MVEC)","article_published_time":"2023-06-01T06:45:24+00:00","author":"Alice Black","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Alice Black","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/#article","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/"},"author":{"name":"Alice Black","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311"},"headline":"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older","datePublished":"2023-06-01T06:45:24+00:00","mainEntityOfPage":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/"},"wordCount":232,"articleSection":["Show all","COVID-19","External News"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/","url":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/","name":"ATAGI \u5173\u4e8e\u4f18\u5148\u4f7f\u7528\u4e8c\u4ef7 COVID-19 \u75ab\u82d7\u5bf9 12 \u5c81\u6216\u4ee5\u4e0a\u4eba\u7fa4\u8fdb\u884c\u521d\u6b21\u63a5\u79cd\u7684\u5efa\u8bae - \u58a8\u5c14\u672c\u75ab\u82d7\u6559\u80b2\u4e2d\u5fc3 (MVEC)","isPartOf":{"@id":"https:\/\/mvec.mcri.edu.au\/#website"},"datePublished":"2023-06-01T06:45:24+00:00","author":{"@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311"},"breadcrumb":{"@id":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mvec.mcri.edu.au\/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mvec.mcri.edu.au\/"},{"@type":"ListItem","position":2,"name":"ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older"}]},{"@type":"WebSite","@id":"https:\/\/mvec.mcri.edu.au\/#website","url":"https:\/\/mvec.mcri.edu.au\/","name":"\u58a8\u5c14\u672c\u75ab\u82d7\u6559\u80b2\u4e2d\u5fc3 (MVEC)","description":"\u5728\u8fd9\u91cc\u627e\u5230\u60a8\u6240\u6709\u7684\u75ab\u82d7\u76f8\u5173\u4fe1\u606f\u3002","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mvec.mcri.edu.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/mvec.mcri.edu.au\/#\/schema\/person\/b6f69ebc60314c6d952badec26f9c311","name":"\u827e\u4e3d\u4e1d\u00b7\u5e03\u83b1\u514b","url":"https:\/\/mvec.mcri.edu.au\/zh\/author\/alice-black\/"}]}},"modified_by":"Alice Black","_links":{"self":[{"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/posts\/18227","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/users\/493"}],"replies":[{"embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/comments?post=18227"}],"version-history":[{"count":0,"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/posts\/18227\/revisions"}],"wp:attachment":[{"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/media?parent=18227"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/categories?post=18227"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mvec.mcri.edu.au\/zh\/wp-json\/wp\/v2\/tags?post=18227"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}